Deutsche Bank AG Has $63,000 Stock Position in Nature’s Sunshine Products, Inc. $NATR

Deutsche Bank AG reduced its position in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 29.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,990 shares of the company’s stock after selling 2,034 shares during the quarter. Deutsche Bank AG’s holdings in Nature’s Sunshine Products were worth $63,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in NATR. Millennium Management LLC acquired a new position in shares of Nature’s Sunshine Products during the 4th quarter valued at about $1,135,000. Dimensional Fund Advisors LP increased its position in shares of Nature’s Sunshine Products by 3.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 856,701 shares of the company’s stock valued at $12,560,000 after purchasing an additional 30,464 shares during the period. Janney Montgomery Scott LLC acquired a new stake in shares of Nature’s Sunshine Products during the 1st quarter valued at about $340,000. Mackenzie Financial Corp acquired a new position in shares of Nature’s Sunshine Products in the 1st quarter worth approximately $287,000. Finally, BNP Paribas Financial Markets lifted its holdings in shares of Nature’s Sunshine Products by 346.9% during the fourth quarter. BNP Paribas Financial Markets now owns 11,719 shares of the company’s stock valued at $172,000 after acquiring an additional 9,097 shares during the period. Hedge funds and other institutional investors own 79.40% of the company’s stock.

Insiders Place Their Bets

In other news, CAO Jonathan David Lanoy sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $16.51, for a total value of $82,550.00. Following the transaction, the chief accounting officer owned 50,051 shares in the company, valued at approximately $826,342.01. The trade was a 9.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the business’s stock in a transaction dated Friday, June 27th. The shares were sold at an average price of $11.46, for a total value of $32,713,796.22. The disclosure for this sale can be found here. Insiders sold a total of 2,869,603 shares of company stock valued at $32,961,680 in the last 90 days. Corporate insiders own 5.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on NATR shares. DA Davidson restated a “buy” rating and set a $19.00 price target on shares of Nature’s Sunshine Products in a research report on Tuesday, June 3rd. Canaccord Genuity Group increased their target price on Nature’s Sunshine Products from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Nature’s Sunshine Products currently has a consensus rating of “Buy” and a consensus price target of $19.67.

Nature’s Sunshine Products Stock Performance

NASDAQ NATR opened at $16.85 on Tuesday. Nature’s Sunshine Products, Inc. has a 52-week low of $11.01 and a 52-week high of $18.06. The stock has a market cap of $297.23 million, a PE ratio of 22.77 and a beta of 1.11. The firm has a 50-day moving average of $15.59 and a 200-day moving average of $14.20.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.19. The firm had revenue of $114.75 million for the quarter, compared to analysts’ expectations of $113.10 million. Nature’s Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.

Nature’s Sunshine Products Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.